Fund High-Impact Clinical Research. Support milestone-based biomedical projects at leading hospitals and universities in the U.S. and internationally.
BioCrowd enables donors to support clinical and translational research using established charitable channels. You can give through:
Support specific diseases or institutions. Fund clinical and translational milestones. Accelerate therapies toward patients.
In some cases, donors may earmark support for a specific patient community or research initiative. A family with a sick child with a rare disease can drive a potential cure — taking on a "Citizen Scientist" role.
BioCrowd does not receive or custody DAF funds. All DAF grants are processed directly through the donor's DAF sponsor and sent to the eligible institution or nonprofit.
Browse institution-approved research campaigns and choose the project that aligns with your philanthropic goals.
Log in to your DAF account and recommend a grant to the eligible institution or nonprofit associated with your chosen project.
Your DAF sponsor performs its standard due diligence and processes the grant recommendation per its policies.
Funds are sent directly to the eligible institution or nonprofit — not through BioCrowd.
You receive regular, transparent progress updates tied to the scientific milestones your donation helps achieve.
All grants are handled by the donor's DAF sponsor and the receiving institution.
BioCrowd enables venture philanthropy in biotech by connecting donors directly to cancer research funding programs, Alzheimer's research initiatives, rare disease research, early clinical trials, and translational therapeutic programs.
Donors can support high-impact projects at leading academic medical centers while receiving transparent, milestone-based reporting and a tax deduction.
Donors may also create a new DAF with the sponsor of their choice.
Advancing novel therapies and early detection approaches.
Supporting early-stage translational programs targeting neurodegeneration.
Funding proof-of-concept programs in underserved disease areas.
Bridging the gap between preclinical discovery and first-in-human studies.
Moving validated research from the bench toward patient benefit.
Supporting NASA ISS-based biomedical research programs. Learn more →
Your donation can move a promising research project from the lab toward real patient impact.